Register for email alerts and news feeds:
This journal | BMJ Group
rss
Evidence-Based Nursing 2004;7:14; doi:10.1136/ebn.7.1.14
Copyright © 2004 by BMJ Publishing Group Ltd & RCN Publishing Company Ltd.
Evidence-Based Nursing 2004; 7:14
© 2004 BMJ Publishing Group Ltd. & Royal College of Nursing

Treatment

Review: personalised risk communication may improve uptake of screening tests more than general risk communication

Edwards A, Unigwe S, Elwyn G, et al. Personalised risk communication for informed decision making about entering screening programs. Cochrane Database Syst Rev 2003;(1):CD001865 (latest version 18 Nov 2002).

Q Do personalised risk communication (PRC) strategies about participation in health screening programmes increase screening uptake compared with general risk communication (GRC) strategies?

Key Words: mass screening • decision making • communication • patient participation

The first 150 words of the full text of this article appear below.

METHODS

Data sources: Cochrane Consumers and Communication Review Group specialised register (March 2001), Medline (1985–2001), EMBASE/Excerpta Medica (1985–2001), CancerLit (1985–2001), CINAHL (1985–2001), ClinPSYC (1989–2001), and Science Citation Index Expanded (March 2002); and hand searches of bibliographies of key publications, journals, and authors.

Study selection and assessment: randomised controlled trials (RCTs) that included participants facing real life decisions about whether to be screened (an investigation done by a health professional); compared PRC with GRC; and assessed cognitive, affective, behavioural, health status, or economic outcomes. Exclusion criteria: studies of mass communication or military, school, or prison interventions. Quality of individual studies was assessed using the Jadad scale and a second method score.

Outcome: uptake of screening test.

MAIN RESULTS

13 trials met the selection criteria. Studies addressed screening for breast cancer (10 trials), cervical cancer (1 trial), prostate cancer (1 trial), colorectal cancer (1 trial), and high cholesterol (2 trials). Overall quality of individual studies . . . [Full text of this article]

Dawn Dowding, RGN, PhD

Department of Health Sciences and the Hull York Medical School
University of York, York, UK


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Login to EBN

RCN Publishing archive